Patient-Derived Xenograft Models of Lung Cancer

Lung cancer is the most common type of cancer worldwide, accounting for 13% of the total number of new diagnoses and is classified according to histological type by the size and appearance of cells: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Given the prominence of lung cancer diagnosed in the population, predictive preclinical models are essential for treatment development. Our lung cancer models are known to be the most predictive and provide the most accurate approach to evaluating an agents efficacy prior to entering the clinic. Crown Bioscience offers a large collection of over 300 well characterized models including 70 SCLC models, as well as primary and metastatic models. More

Benefits of Crown Bioscience's Lung Cancer PDX Models

Our lung cancer patient-derived xenograft models offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, patient derived xenografts reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime^® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER	CANCER TYPE	CANCER SUBTYPE	DESCRIPTION	# per page
LU0009	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of right lung, central type with massive necrosis, moderately differentiated, tumor mass: 10cm x 6cm x 5cm. Regional LN: paratracheal LN (2/6). IHC results: HER-1(-), HER-2(-), p53(+ >75%), p170(-), Ki-67(+ 25~50%), p63(+ >75%), VEGF(+), Top-IIa(+ 25~50%), p16(-).	CLICK TO VIEW
LU0038	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of left lung, grade I-II, tumor mass: 4.5cm x 4cm x 5cm. No maglignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/4), LN of inferior pulmonary ligament (0/2), carina of trachea LN (0/2), LN of left pulmonary vein (2/6).	CLICK TO VIEW
LU0299	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, no visible malignant cells adjacent to upperside and downside of surgery cut, no malignant cells in LN of hilum of lung LN (0/2) and eminence LN (0/4).	CLICK TO VIEW
LU0330	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, moderately differentiated.	CLICK TO VIEW
LU0350	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, no visible malignant cells adjacent to bronchus stump, no malignant cells in LN of inferior pulmonary. veins LN (0/1), subeminence LN (0/3).	CLICK TO VIEW
LU0357	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, no visible malignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/2), the second hilum of lung (0/2), superior mediastinal LN (0/1), inferior carina of trachea LN (0/2), anterior tracheal LN (0/1).	CLICK TO VIEW
LU0367	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, no visible malignant cells adjacent to superior stump, no malignant cells in LN of hilum of lung LN (0/8), eminence LN (0/5), paratracheal LN (0/7), inferior pulmonary veins LN (0/1).	CLICK TO VIEW
LU0377	Lung Cancer	NSCLC, ADC	Adenocarcinoma of lung, poorly differentiated, no visible malignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/3), the second hilum of lung LN (0/2), carina of trachea LN (0/1).	CLICK TO VIEW
LU0387	Lung Cancer	NSCLC, ADC	Adenocarcinoma of lung, malignant cells adjacent to bronchial stump. Regional LN: superior mediastinal LN (2/2), inferior carina of trachea LN (1/1), subclavian LN (1/1), hilum of lung LN (3/3), second hilum of lung LN (0/2).	CLICK TO VIEW
LU0395	Lung Cancer	NSCLC, SCC	Adenoacanthoma of lung, no visible malignant cells adjacent to bronchus stump, malignant cells in superior mediastinum LN (1/3), eminence LN (0/2), inferior pulmonary ligament (0/2), and hilum of lung LN (1/2).	CLICK TO VIEW
LU0697	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No malignant cells adjacent to bronchus stump. Regional LN: superior mediastinal LN (0/6), inferior carina of trachea LN (0/1).	CLICK TO VIEW
LU0741	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No malignant cells adjacent to bronchial stump. Regional LN: LN between lobules of lung (0/2), inferior pulmonary vein LN (0/1), superior mediastinal LN (0/6), subclavian LN (0/2), carina of trachea LN (0/4), right hilum of lung LN (2/2). Tumor embolus were observed in inferior pulmonary vein.	CLICK TO VIEW
LU0743	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No malignant cells adjacent to bronchial stump. Regional LN: inferior pulmonary vein LN (0/1), paraaotic LN (0/6), hilum of lung LN (1/6), inferior carina of trachea LN (1/3). Malignant cells invaded pericardium and fiber of chest wall.	CLICK TO VIEW
LU0748	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung.	CLICK TO VIEW
LU0755	Lung Cancer	NSCLC, SCC	NA for clinical diagnosis info.	CLICK TO VIEW
LU0858	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, poorly differentiated. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/2), superior mediastinal LN (0/2), the tenth group LN (0/5).	CLICK TO VIEW
LU0860	Lung Cancer	Neurofibroma	NA for clinical diagnosis info.	CLICK TO VIEW
LU0861	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No maglignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/1).	CLICK TO VIEW
LU0876	Lung Cancer	NSCLC, SCC	NA for clinical diagnosis info.	CLICK TO VIEW
LU0884	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma in lung. Malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/1), the second hilum of lung LN (0/2), superior mediastinal LN (0/2), carina of trachea LN (0/2), LN between lobules of lung (0/1).	CLICK TO VIEW
LU0894	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/1), anterior esophageal and posterior vena cava LN (0/2), carina of trachea LN (0/2).	CLICK TO VIEW
LU1116	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of left lung.	CLICK TO VIEW
LU1143	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of right lung.	CLICK TO VIEW
LU1144	Lung Cancer	NSCLC	Adenocarcinoma of right lung, poorly differentiated.	CLICK TO VIEW
LU1147	Lung Cancer	NSCLC, ADC	Poorly differentiated cancer of inferior left lung, tumor mass: 5.5cm x 4.5cm x 4cm, tumor cell appear as infiltrative growth and irregular adenoid type with massive necrosis.	CLICK TO VIEW
LU11548	Lung Cancer	NSCLC	Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK, CLOT AND CYTOSPIN PREP.	CLICK TO VIEW
LU1155	Lung Cancer	SCC	Poorly differentiated squamous cell carcinoma	CLICK TO VIEW
LU11553	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer, LUNG CARCINOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11554	Lung Cancer	NSCLC	NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11561	Lung Cancer	NSCLC	NA	CLICK TO VIEW
LU11568	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP.	CLICK TO VIEW
LU11574	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP.	CLICK TO VIEW
LU11575	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. METASTATIC CARCINOMA, PD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11576	Lung Cancer	NSCLC	Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11584	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11586	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. CARCINOMA, PD FAVOR NON-SMALL CELL CARCINOMA OF LUNG. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP.	CLICK TO VIEW
LU11592	Lung Cancer	NSCLC	Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11595	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. SQUAMOUS CELL CARCINOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU1160	Lung Cancer	NSCLC, SCC	Poorly differentiated cancer of right lung.	CLICK TO VIEW
LU11605	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11607	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. NO DEFINITE MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION OR CYTOSPIN PREP.	CLICK TO VIEW
LU11612	Lung Cancer	NSCLC	NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11622	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11624	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. INVASIVE PD ADENOSQUAMOUS CARCINOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11631	Lung Cancer	NSCLC, ADC	N/A	CLICK TO VIEW
LU11634	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. METASTATIC ADENOCARCINOMA. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11644	Lung Cancer	SCLC	Non-Small Cell Lung Cancer. CARCINOMA, PD. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11652	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11672	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. ADENOCARCINOMA. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11682	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROX. 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 5% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11684	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11685	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11692	Lung Cancer	NSCLC	NA for clinical diagnosis info.. Pathol comment: C/W DIAGNOSIS. APPROX. 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 30% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11693	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11694	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11713	Lung Cancer	SCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11714	Lung Cancer	SCLC	Non-Small Cell Lung Cancer. Non-small cell carcinoma, PD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11717	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11722	Lung Cancer	NSCLC	NA for clinical diagnosis info. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 5% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11733	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11736	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11753	Lung Cancer	SCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11760	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU11772	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Non-small cell carcinoma, MD with squamous features. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 40% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11784	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11786	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP.	CLICK TO VIEW
LU11796	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Non-small cell carcinoma, PD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11801	Lung Cancer	NSCLC	Non-small cell lung cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11805	Lung Cancer	NSCLC	Non-small cell lung cancer. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK AND CYTOSPIN PREP. C/W REFERRING DIAGNOSIS.	CLICK TO VIEW
LU11815	Lung Cancer	NSCLC	Non-small cell lung cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU11835	Lung Cancer	NSCLC	Non-small cell lung cancer, Malignant neoplasm of left upper lobe. Pathol comment: C/W HISTOLOGIC DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 90% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11836	Lung Cancer	NSCLC	Non-small cell lung cancer with serous features. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11842	Lung Cancer	NSCLC	Non-small cell lung cancer. Metastatic adenocarcinoma of the lung. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11855	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU11856	Lung Cancer	NSCLC	Non-small cell lung carcinoma, Large cell carcinoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 30% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11873	Lung Cancer	NSCLC	Non-small cell lung cancer. Pathol comment: MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK. APPROXIMATELY 90% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. C/W DIAGNOSIS.	CLICK TO VIEW
LU11876	Lung Cancer	NSCLC	Non-small cell lung cancer. Pathol comment: APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 50% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11882	Lung Cancer	NA	NA for clinical diagnosis info. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11885	Lung Cancer	NSCLC	Pathol comment: Non-small cell lung carcinoma. Metastatic carcinoma consistent with lung primary. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 50% NECROSIS. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU11894	Lung Cancer	NSCLC	Non-small cell lung cancer. Adenocarcinoma. Pathol comment: Approximately 90% of the tissue involved by malignant tumor in sections examined. 10% necrosis. c/w NSCLC. Approximately 30% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU11942	Lung Cancer	NSCLC	Lung carcinoma.	CLICK TO VIEW
LU11949	Lung Cancer	NSCLC	Non-small cell lung cancer, sclerosing bronchioloalveolar carcinoma.	CLICK TO VIEW
LU11951	Lung Cancer	NSCLC	NA for clinical diagnosis info.	CLICK TO VIEW
LU11953	Lung Cancer	SCLC	Non-small cell lung cancer. Submitted specimen consists of malignant epithelial and mesenchymal components. this case was reviewed in intra-department consultation with consensus in interpretation.	CLICK TO VIEW
LU11954	Lung Cancer	NSCLC	Mediastinal mass. Spindle cell sarcoma.	CLICK TO VIEW
LU1201	Lung Cancer	NA	NA	CLICK TO VIEW
LU1204	Lung Cancer	NSCLC, SCC	Poorly differentiated carcinoma of left lung, considered poorly differentiated adenosquamous carcinoma.	CLICK TO VIEW
LU1206	Lung Cancer	NSCLC, SCC	Adenosquamous carcinoma of left lung, tumor mass: 3cm x 3cm x 2.5cm. Regional LN: hilum of lung LN (2/4), the fifth group LN (1/1), the seventh group LN (0/5), the ninth group LN (0/2), paratracheal LN (0/7).	CLICK TO VIEW
LU1215	Lung Cancer	NSCLC, ADC	Adenocarcinoma of right lung, moderately differentiated, tumor mass: 16cm x 14cm x 3cm. No maglignant cells adjacent to bronchial stump. Regional LN: the third group LN (1/2), LN of vena cava (1/1), the second group LN (0/4), the second and forth group LN (0/4), the seventh group LN (0/1), the ninth group LN (0/3), the tenth group LN (0/2), the eleventh group LN (0/1).	CLICK TO VIEW
LU1219	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma	CLICK TO VIEW
LU1235	Lung Cancer	NSCLC, ADC	Adenosquamous carcinoma with part of bronchioloalveolar carcinoma of left lung, tumor mass: 2.5cm x 2cm x 2cm.	CLICK TO VIEW
LU1256	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of left lung, moderately differentiated.	CLICK TO VIEW
LU1258	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, moderately differentiated. The tumor forms irregular nest or funicular structures and has an infiltrative growth pattern. Necrosis may be seen. Regional LN: the first group LN (1/1), the ninth group LN (0/1).	CLICK TO VIEW
LU1267	Lung Cancer	SCLC, NEC	Small cell lung cancer. Regional LN: parabronchial LN (1/2), the eleventh group LN (4/4), the seventh group LN (0/1), the tenth group LN (0/2).	CLICK TO VIEW
LU1271	Lung Cancer	NSCLC, LCLC	Large cell undifferentiated carcinoma	CLICK TO VIEW
LU1292	Lung Cancer	NSCLC, SCC	Squmaous cell carcinoma of left lung, poorly differentiated, malignant cells invaded visceral pleura, tumor mass: 3.5cm x 2.8cm x 2.8cm. Regional LN: parabronchial LN (0/2). IHC results: CK5/6(+), CK7(-), P16(-), P53(-), Caspase-3(-).	CLICK TO VIEW
LU1302	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of left lung, moderately differentiated.	CLICK TO VIEW
LU1380	Lung Cancer	NSCLC, ADC	Adenocarcinoma of right lung with part of bronchioloalveolar carcinoma, grade II+, no malignant cells adjacent to bronchial stump. Regional LN: parabronchial LN (0/5). IHC results: CK7(+), CK5/6(-), TTF1(+), P63(+), Sur(+).	CLICK TO VIEW
LU13944	Lung Cancer	NSCLC	metastaic adenocarcinoma , c/w primary lung origin. Pathol comment: APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU13952	Lung Cancer	LY	NA for clinical diagnosis info.. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU13953	Lung Cancer	NA	NSCLC, metastatic ADC. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU13956	Lung Cancer	NSCLC	metastaic carcinoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 20% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU14020	Lung Cancer	SCLC	Small Cell Lung Carcinoma. Pathol comment: C/W DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU1419	Lung Cancer	NSCLC, SCC	N/A	CLICK TO VIEW
LU1423	Lung Cancer	NSCLC, SCC	Squmaous cell carcinoma of left lung, poorly differentiated, no malignant cells invaded visceral pleura, tumor mass: 3.3cm x 3.5cm x 2cm. Regional LN: parabronchial LN (0/6). IHC results: CK5/6(+), CK7(-), Caspase-3(-), BCL-2(+/-), NF-K B(-).	CLICK TO VIEW
LU1429	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of right lung, grade II-III	CLICK TO VIEW
LU1452	Lung Cancer	NSCLC, ADC	adenocarcinoma of left lung, invaded adipose tissue of mediastinum and pericardium.	CLICK TO VIEW
LU1480	Lung Cancer	SCLC, NEC	Small cell lung cancer, tumor mass: 5 x 3 x 3cm. Regional LN: bronchial stump LN (2/4).	CLICK TO VIEW
LU1487	Lung Cancer	LY	Considered poorly differentiated adenocarcinoma of lung on basis of HE&IHC.	CLICK TO VIEW
LU1508	Lung Cancer	SCLC, NEC	Atypical carcinoid, tumor mass: 3.8cm x 3cm x 2cm. No malignant cells adjacent to adventitia. Regional LN: paratracheal LN (0/5), inferior carina of trachea LN (0/9), hilum of lung LN (0/2), posterior pretracheal vein LN (10/10). IHC results: SYN(+++), CgA(-), NSE(++), CK(+-), CD56(focal +).	CLICK TO VIEW
LU1513	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma, central type, poorly differentiated with necrosis, tumor mass: 3cm x 3cm x 2cm. No malignant cells adjacent to bronchial stump. Regional LN: parabronchial LN (0/5), hilum of lung LN (0/3), inferior aortic arch LN (0/3).	CLICK TO VIEW
LU1542	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma. No malignant cells adjacent to bronchial stump. Regional LN: LN between lobules of lung (0/2), the second hilum of lung LN (0/2), inferior carina of trachea LN (0/3), superior mediastinal LN (0/6).	CLICK TO VIEW
LU16057	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Metastatic carcinoma, MPD. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU1627	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No malignant cells adjacent to bronchial stump. Regional LN: LN of inferior pulmonary veins (0/1), LN between lobules of lung (0/2), hilum of lung LN (1/2), the second hilum of lung LN (1/2), superior-anterior mediastinal LN (0/7), inferior carina of trachea LN (0/4), left pulmonary artery window LN (0/5).	CLICK TO VIEW
LU1656	Lung Cancer	NSCLC, SCC	Carcinosarcoma. No malignant cells adjacent to bronchus stump. Regional LN: the second group LN (0/1), the forth group LN (0/3), inferior carina of trachea LN (0/2), the ninth group LN (0/2), the tenth group LN (0/1), the eleventh group LN (0/2). IHC results: CK(+), Vim(+), Act(-), NSE(-), Syn(-), CD56 (+/-), Chr-A (-).	CLICK TO VIEW
LU1661	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/3), aorticopulmonary window LN (0/1), superior mediastinal LN (0/2), carina of trachea LN (1/4).	CLICK TO VIEW
LU1690	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, tumor mass: 3cm x 1cm x 2cm. Malignant cells adjacent to bronchus stump. Regional LN: the second hilum of lung LN (3/3), LN of inferior pulmonary ligament (0/3), inferior carina of trachea LN (5/8), LN between lobules of lung (0/1), hilum of lung LN (3/3).	CLICK TO VIEW
LU1775	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma. No malignant cells adjacent to bronchus stump. Regional LN: inferior carina of trachea LN (2/3), superior mediastinal LN (2/4).	CLICK TO VIEW
LU1776	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma. No malignant cells adjacent to bronchus stump. Regional LN: LN between lobules of lung (0/2), superior-anterior mediastinal LN (0/1), carina of trachea LN (0/6), subclavian LN (0/1), superior mediastinal LN (0/2).	CLICK TO VIEW
LU1828	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma. No malignant cells adjacet to bronchus stump. Regional LN: hilum of lung LN (0/4), LN of inferior pulmonary ligament (0/2), carina of trachea LN (0/4).	CLICK TO VIEW
LU1868	Lung Cancer	NSCLC, SCC	Poorly-moderately differentiated squamous cell carcinoma	CLICK TO VIEW
LU1901	Lung Cancer	NSCLC, LCLC	Large cell anaplastic carcinoma	CLICK TO VIEW
LU1902	Lung Cancer	NSCLC, LCLC	Large cell anaplastic carcinoma	CLICK TO VIEW
LU2033	Lung Cancer	NSCLC, ADC	Adenocarcinoma with mixed subtypes	CLICK TO VIEW
LU2038	Lung Cancer	NSCLC, ADC	Adenosquamous carcinoma	CLICK TO VIEW
LU2042	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma, NOS	CLICK TO VIEW
LU2049	Lung Cancer	NSCLC, ADC	Adenocarcinoma, NOS	CLICK TO VIEW
LU2051	Lung Cancer	NSCLC	Large Cell Neuroendocrine Carcinoma Lung	CLICK TO VIEW
LU2055	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma	CLICK TO VIEW
LU2057	Lung Cancer	SCLC	Squamous cell carcinoma, large cell, nonkeratinizing, NOS. Pathology QC on PDX: Small cell carcinoma.	CLICK TO VIEW
LU2071	Lung Cancer	NSCLC, SCC	squamous cell carcinoma	CLICK TO VIEW
LU2080	Lung Cancer	NSCLC, SCC	NA for clinical diagnosis info. Pathology QC: squamous cell carcinoma (P7)	CLICK TO VIEW
LU2086	Lung Cancer	NSCLC, SCC	Lung squaous cell carcinoma.	CLICK TO VIEW
LU2403	Lung Cancer	NSCLC, ADC	N/A	CLICK TO VIEW
LU2417	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU2445	Lung Cancer	NSCLC	Carcinosarcoma. No malignant cells adjacent to bronchus stump. Regional LN: the second group LN (0/1), the forth group LN (0/3), inferior carina of trachea LN (0/2), the ninth group LN (0/2), the tenth group LN (0/1), the eleventh group LN (0/2). IHC results: CK(+), Vim(+), Act(-), NSE(-), Syn(-), CD56 (+/-), Chr-A (-).	CLICK TO VIEW
LU2455	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU2503	Lung Cancer	NSCLC, ADC	Moderately-poorly differentiated adenosquamous carcinoma	CLICK TO VIEW
LU2504	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma, moderately-well differentiated. No malignant cells adjacent to bronchus stump. Regional LN: hilum of lung LN (0/3), IHC: P63(++),TTF-1(-), CK5(+++),CK14(+++), EGFR(+),Ki-67(10%+),CK7(+/-),ERCC-1(-),RRM-1(-),Tubulin b3(-),ER(-),ER-b(-).1. (Group 10) 2. (group 7) no metastasis in LN (0/1,0/1).	CLICK TO VIEW
LU2505	Lung Cancer	NSCLC, ADC	Adenocarcinoma, poorly differentiated, malignant cells diffuse infiltrated in lung with massive necrosis. No malignant cells adjacet to stump. Regional LN: hilum of lung LN (3/3), the eleventh group LN (0/2),the fivth group LN (0/1), the seventh group LN (0/3). IHC results: Syn(-), CHgA(+/-), TTF-1(+++), SPB(-), CK7(++), EGFR(-), ER(-), ER-(++), CK20(-), RRM-1(++), CEA(+++), CK34BE12(+), Tubulin b3(+), ERCC-1(++), Ki-67(50%+), CD34(blood vessel +).	CLICK TO VIEW
LU2509	Lung Cancer	PNET	Primitive neuroectodermal tumor (PNET) of left lung.IHC results: Vimentin(+++), CD99(++), Ki67(+)<40%, Bcl-2(++), CD56(++), S-100(+/-).	CLICK TO VIEW
LU2511	Lung Cancer	NSCLC, LCLC	Large cell undifferentiated carcinoma, tumor mass: 7cm x 6cm x 6cm, no visible malignant cells adjacent to bronchial stump. Regional LN: carina of trachea LN (0/2), the sixth group LN (0/2), inferior pulmonary vein LN (0/2), carina of trachea LN (0/2), superior mediastinal LN (0/1),LN between lobules of lung (0/1), the fourth group LN (0/3). IHC results: CK(+), Vim(-), EMA(+), P63(-/+), CK7(-), Syn(+), CD56(-).	CLICK TO VIEW
LU2512	Lung Cancer	NSCLC, ADC	Adenocarcinoma of lung, tumor mass: 4cm x 4cm x 3cm, malignant cells invaded soft tissues external bronchial stump. Regional LN: the fourth group LN (4/4), the ninth group LN (1/2), inferior carina of trachea LN (1/2), the second group LN (3/3), the second carina of trachea LN (2/2).	CLICK TO VIEW
LU2514	Lung Cancer	SCLC, NEC	Small cell carcinoma, tumor mass: 7cm x 4.5cm x 3cm, no visible malignant cells adjacent to bronchial stump. Regional LN: hilum of lung LN (0/1), LN of inferior pulmonary ligament (0/1). IHC results: CK(-/+), NSE(+), Syn(+), CD56(+), Chr-A(+/-).	CLICK TO VIEW
LU2527	Lung Cancer	NEC	Neuroendocrine carcinoma of lung, moderately differentiated, tumor mass: 4.5 x 3.2 x 3cm. Regional LN: hilum of lung LN (2/2), NO.5 LN 0/4, NO.9 LN 0/1. IHC results: CK7(-), CK34(-), CK5/6(-), CEA(-), P63(-), Ki67(++)90%, CgA(+), Syn(-), SCLC(++), TTF(++), ERCC-1(-), VEGFR(++), TP(-), Her-2(-), EGFR(++), B-microtubulin(+++).	CLICK TO VIEW
LU2529	Lung Cancer	Clear cell carcinoma, sarcomatoid carcinoma	Clear cell carcinoma with neuroendocrine carcinoma, tumor mass: 2.5 x 2 x 2.5cm. Regional LN: LN between lobules of lung (0/1), inferior carina of trachea LN (0/2), LN of inferior parapulmonary vein (0/2), superior mediastinal LN (1/2), hilum of lung LN (0/2). IHC results: CK(+), Vim(+/-), HMB45(-), S-100(-/+), Mart-1(-), NSE(+), Syn(-), CD56(-), Chr-A(+).	CLICK TO VIEW
LU2535	Lung Cancer	NSCLC, ADC	Poorly differentiated adenocarcinoma of lung, tumor mass: 4.5 x 4 x 2.5cm. Regional LN: hilum of lung LN (0/1), superior mediastinal LN (3/9), LN of inferior parapulmonary vein (1/1), inferior carina of trachea LN (0/9). IHC results: CK8/18(+),CK7(+++), CK34(+), CK5/6(-), K167(+)10%, CgA(-), HMB45(-), ERCC-1(-), VECFR(++), TP(-), Her-2(+), Syn(-), TTF(++), BGFR(++), B-microtubulin(+++), P53(++), CD34(blood vessel +).	CLICK TO VIEW
LU2537	Lung Cancer	NSCLC	Lung cancer (adenoacanthoma) metastasis to lymphonodi. Regional LN: right neck triangle LN (5/5), right superior clavicular LN (5/5).	CLICK TO VIEW
LU2540	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung	CLICK TO VIEW
LU2551	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU2555	Lung Cancer	NSCLC, ADC	NA for clinical diagnosis info.	CLICK TO VIEW
LU2567	Lung Cancer	NEC	NA	CLICK TO VIEW
LU2569	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU2675	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU2804	Lung Cancer	NA	NA	CLICK TO VIEW
LU3007	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of left lung, grade II-III, no visible malignant cells adjacent to visceral pleura. IHC results: CK5/6(+), CK7(-), TTF(-), SPA(-), VEGF(-). Regional LN: parabronchial LN (0/5), the forth group LN (0/1), the tenth group LN (0/3), the eleventh group LN (0/1).	CLICK TO VIEW
LU3057	Lung Cancer	NSCLC, ADC	Poorly differentiated adenocarcinoma of lung, tumor mass: 1.5 x 2 x 1.5cm. Massive malignant cells and lymphocyte infiltrating may be seen in hyperplastic fibrous tissue. IHC results: CK7(+), CK5/6(-), P53(+), VEGF(+/-).	CLICK TO VIEW
LU3073	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of lung, grade II-III	CLICK TO VIEW
LU3075	Lung Cancer	NSCLC, SCC	NSCLC, tumor mass: 2.5 x 1.5 x 1cm.	CLICK TO VIEW
LU3133	Lung Cancer	NSCLC, ADS	Adenosquamous carcinoma of lung with necrosis. Regional LN: parabronchial LN (0/4), paratracheal LN (0/1), inferior carina of trachea LN (0/1), hilum of lung LN (0/2), LN between lobules of lung (0/3).	CLICK TO VIEW
LU3345	Lung Cancer	SCC	Lung: poorly differentiated squamous cell carcinoma. Two of twelve lymph nodes involved by metastatic carcinoma (2/12)	CLICK TO VIEW
LU5137	Lung Cancer	NSCLC, LCNEC	large cell carcinoma large cell neuroendocrine carcinoma	CLICK TO VIEW
LU5138	Lung Cancer	NSCLC, SCC	squamous carcinomasquamous cell carcinoma	CLICK TO VIEW
LU5139	Lung Cancer	SCLC	squamous carcinomamoderately-differentiated invasive squamous cell carcinoma	CLICK TO VIEW
LU5146	Lung Cancer	NSCLC, SCC	squamous carcinomapoorly-differentiated squamous cell carcinoma	CLICK TO VIEW
LU5147	Lung Cancer	NSCLC, SCC	squamous carcinomasquamous cell carcinoma	CLICK TO VIEW
LU5148	Lung Cancer	NSCLC, SCC	squamous carcinomasquamous cell carcinoma	CLICK TO VIEW
LU5149	Lung Cancer	NSCLC, SCC	squamous carcinomametastatic poorly differentiated carcinoma	CLICK TO VIEW
LU5150	Lung Cancer	NSCLC, ADC	adenocarcinoma metastatic poorly differentiated adenocarcinoma	CLICK TO VIEW
LU5151	Lung Cancer	NSCLC, ADC	adenocarcinomamoderately differentiated pulmonary adenocarcinoma	CLICK TO VIEW
LU5152	Lung Cancer	NSCLC, ADC	adenocarcinoma non-small cell carcinoma, spindle cell type	CLICK TO VIEW
LU5153	Lung Cancer	NSCLC, ADC	adenocarcinomapoorly-differentiated adenocarcinoma	CLICK TO VIEW
LU5155	Lung Cancer	NSCLC, ADC	adenocarcinomametastatic adenocarcinoma	CLICK TO VIEW
LU5157	Lung Cancer	NSCLC, ADC	adenocarcinomanon-small cell lung carcinoma, favor adenocarcinoma	CLICK TO VIEW
LU5159	Lung Cancer	SCLC	adenocarcinomaadenocarcinoma with focal squamous (less than 20%) differentiation as well as clear cell differentiation	CLICK TO VIEW
LU5160	Lung Cancer	NSCLC, ADC	adenocarcinomasolid-predominant adenocarcinoma	CLICK TO VIEW
LU5161	Lung Cancer	NSCLC, SCC	non-small cell lung cancer metastatic carcinoma with clear cell features	CLICK TO VIEW
LU5162	Lung Cancer	NSCLC, ADC	non-small cell lung cancer metastatic poorly differentiated carcinoma	CLICK TO VIEW
LU5165	Lung Cancer	NSCLC, ADC	adeno	CLICK TO VIEW
LU5167	Lung Cancer	SCLC	broncogenic small cell lung cancer	CLICK TO VIEW
LU5171	Lung Cancer	SCLC	small cell lung carcinoma small cell lung carcinoma	CLICK TO VIEW
LU5172	Lung Cancer	NSCLC (KRAS mut)	non-small cell lung cancer. Pathol comment: tumor cells present in cell block c/w referring diagnosis. tumor cells present in cytospin prep.	CLICK TO VIEW
LU5173	Lung Cancer	SCLC	Small Cell Lung Carcinoma. Pathol comment: The tissue contains 70% tumor c/w referring diagnosis. Tumor cells present in cytospin prep.	CLICK TO VIEW
LU5174	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. approximately 90% of the tissue involved by tumor in sections examined. tumor cells present in cytospin prep.	CLICK TO VIEW
LU5175	Lung Cancer	NSCLC	NA	CLICK TO VIEW
LU5176	Lung Cancer	NSCLC, ADC (KRAS mut)	non-small cell lung cancer adenocarcinoma. Pathol comment: uncertain tumor cells present in cell block. rare tumor cells present in cytospin prep.	CLICK TO VIEW
LU5178	Lung Cancer	SCLC	small cell lung carcinomaoat cell carcinoma. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep.	CLICK TO VIEW
LU5179	Lung Cancer	SCLC	small cell lung carcinomaanaplastic carcinoma, small cell type. Pathol comment: approximately 60% of the tissue involved by malignant tumor in sections examined. 60% necrosis. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5180	Lung Cancer	SCLC	small cell lung carcinomametastatic small cell carcinoma of lung. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5181	Lung Cancer	NSCLC, SCC	N/A	CLICK TO VIEW
LU5183	Lung Cancer	SCLC	small cell lung carcinomametastatic small cell undifferentiated carcinoma. Pathol comment: c/w referring diagnosis. entire tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5184	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w referring diagnosis. microscopic focus of malignant tumor present in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5185	Lung Cancer	NSCLC, SCC	non-small cell lung carcinoma squamous carcinoma. Pathol comment: approximately 30% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5187	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block section and cytospin prep.	CLICK TO VIEW
LU5188	Lung Cancer	SCLC	small cell lung carcinomaneuroendocrine carcinoma, pd. Pathol comment: c/w referring diagnosis. entire tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5190	Lung Cancer	NSCLC, SCC	non-small cell lung cancer metastatic squamous cell carcinoma, pd. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5191	Lung Cancer	NSCLC (KRAS mut)	non-small cell lung. Pathol comment: c/w referring diagnosis. entire tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5192	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5193	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block section and cytospin prep.	CLICK TO VIEW
LU5194	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block section and cytospin prep.	CLICK TO VIEW
LU5196	Lung Cancer	SCLC	small cell lung carcinoma metastatic small cell carcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5197	Lung Cancer	SCLC	small cell lung carcinomasmall cell carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5199	Lung Cancer	NSCLC (KRAS mut)	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep.	CLICK TO VIEW
LU5200	Lung Cancer	NSCLC (KRAS mut)	non-small cell lung cancer. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5202	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5203	Lung Cancer	SCLC, matched sites	small cell lung carcino mametastatic pd carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5204	Lung Cancer	NSCLC, ADC	non-small cell lung cancer squamous cell lung carcinoma. Pathol comment: c/w referring diagnosis. rare malignant tumor cells present in cell block section. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5206	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5207	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep.	CLICK TO VIEW
LU5208	Lung Cancer	NSCLC (KRAS mut) (EGFR 2+)	Non-Small Cell Lung Cancer. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5209	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep.	CLICK TO VIEW
LU5210	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5211	Lung Cancer	NSCLC, ADC (EGFR hi)	non-small cell lung cancer adenocarcinoma. Pathol comment: c/w diagnosis. approx. 10% of the tissue involved by malignant tumor in sections examined. 20% necrotic. malignant tumor cells in cytospin prep.	CLICK TO VIEW
LU5212	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w referring diagnosis. microscopic focus of malignant tumor present in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5213	Lung Cancer	NSCLC (EGFR hi)	non-small cell lung cancermetastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5215	Lung Cancer	SCLC	small cell lung carcinoma metastatic carcinoma. Pathol comment: c/w diagnosis. approximately 100% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5216	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved malignant tumor in sections examined. 20% necrotic. malignant cells present in cytospin prep.	CLICK TO VIEW
LU5217	Lung Cancer	SCLC	small cell lung carcinomasmall cell carcinoma. Pathol comment: c/w diagnosis. approximately 35% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5218	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 35% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5220	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5221	Lung Cancer	NSCLC, ADC (EGFR hi)	non-small cell lung cancer adenocarcinoma with clear cell change , pd. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved malignant tumor in sections examined. 5% necrotic. malignant cells present in cytospin prep.	CLICK TO VIEW
LU5223	Lung Cancer	SCLC	small cell lung carcinomametastatic carcinoma, ud. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved malignant tumor in sections examined. 10% necrotic. malignant cells present in cytospin prep.	CLICK TO VIEW
LU5228	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5229	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5230	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved malignant tumor in sections examined. focal tumor necrosis. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5231	Lung Cancer	SCLC	non-small cell lung cancer non-small cell carcinoma w/ neuroendocrine features. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. 10% necrotic. small cell carcinoma present. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5233	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5234	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 95% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. malignant tumor cells present in cytospin prep.	CLICK TO VIEW
LU5236	Lung Cancer	SCLC	small cell lung carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. 10% necrosis. c/w small cell carcinoma. approximately 90% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5237	Lung Cancer	NSCLC, ADC	h/o non-small cell lung cancer metastatic adenocarcinoma, mpd. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. 20% necrosis. approximately 60% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5238	Lung Cancer	SCLC	small cell lung carcinoma small cell carcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. 10% necrosis. approximately 80% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5242	Lung Cancer	SCLC	small cell carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. approximately 70% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5243	Lung Cancer	SCLC	small cell carcinomametastatic small cell carcinoma of the lung. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 80% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5245	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: malignant tumor cells present in cell block. consistent with non-small cell carcinoma. approximately 50% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5247	Lung Cancer	NSCLC	non-small cell lung cancer. Pathol comment: approximately 70% of the tissue involved by malignant tumor in sections examined. 5% necrosis. c/w non-small cell carcinoma. approximately 70% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5248	Lung Cancer	SCLC	small cell carcinomasmall cell neuroendocrine carcinoma. Pathol comment: c/w diagnosis. microscopic detached fragments of malignant cells present in tissue sections examined. approximately 90% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5249	Lung Cancer	SCLC	small cell carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. 20% tumor necrosis. approximately 80% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5250	Lung Cancer	SCLC	Small cell carcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. 20% tumor necrosis. approximately 70% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5251	Lung Cancer	NSCLC, SCC	non-small cell lung cancersquamous cell carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. 70% necrosis. approximately 30% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5252	Lung Cancer	NSCLC, ADC (KRAS mut)	non-small cell lung cancer adenocarcinoma. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. approximately 70% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5255	Lung Cancer	SCLC	small cell carcinomasmall cell neuroendocrine carcinoma. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 40% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5256	Lung Cancer	SCLC	small cell carcinoma metastatic small cell carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. 1% necrosis. approximately 80% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5257	Lung Cancer	SCLC	small cell lung carcinoma small cell carcinoma, intermediate cell size. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 80% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5258	Lung Cancer	SCLC	small cell carcinoma small cell carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. marked crush artifact. approximately 70% malignant tumor cells present in cytospin preparation.	CLICK TO VIEW
LU5260	Lung Cancer	NSCLC, ADC (KRAS mut)	non-small cell lung carcinoma poorly differentiated adenocarcinoma	CLICK TO VIEW
LU5261	Lung Cancer	SCLC	small cell carcinoma small cell carcinoma of lung	CLICK TO VIEW
LU5262	Lung Cancer	NSCLC	non-small cell lung cancer poorly differentiated non-small cell carcinoma	CLICK TO VIEW
LU5263	Lung Cancer	SCLC	small cell carcinoma small cell carcinoma	CLICK TO VIEW
LU5264	Lung Cancer	SCLC	small cell carcinoma.	CLICK TO VIEW
LU5265	Lung Cancer	SCLC	small cell lung carcinoma small cell carcinoma	CLICK TO VIEW
LU5266	Lung Cancer	SCLC	small cell carcinoma metastatic small cell carcinoma compatible with previous lung primary	CLICK TO VIEW
LU5268	Lung Cancer	NSCLC, ADC (KRAS mut)	lung carcinoma metastatic adenocarcinoma c/w primary lung	CLICK TO VIEW
LU5269	Lung Cancer	SCLC	small cell carcinoma--	CLICK TO VIEW
LU5271	Lung Cancer	SCLC	small cell carcinoma--	CLICK TO VIEW
LU5349	Lung Cancer	NSCLC	Non-small cell lung carcinoma. Metastatic. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU5350	Lung Cancer	NSCLC	Non-small cell lung carcinoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU5351	Lung Cancer	NSCLC	metastatic carcinoma. Pathol comment: APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. C/W NON-SMALL CELL CARCINOMA. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION.	CLICK TO VIEW
LU5355	Lung Cancer	NSCLC	metastatic squamous cell carcinoma	CLICK TO VIEW
LU5369	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU5371	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MICROSCOPIC FOCUS OF MALIGNANT TUMOR PRESENT IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU5377	Lung Cancer	SCLC	oat cell	CLICK TO VIEW
LU5378	Lung Cancer	SCLC	Small Cell Lung Carcinoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP	CLICK TO VIEW
LU5381	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W REFERRING DIAGNOSIS. MALIGNANT TUMOR CELLS PRESENT IN CELL BLOCK SECTION AND CYTOSPIN PREP.	CLICK TO VIEW
LU5386	Lung Cancer	SCLC	Small Cell Lung Carcinoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU5401	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 30% NECROSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU5406	Lung Cancer	NSCLC	Metastatic Brain Tumor. Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU5407	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU5408	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROX. 10% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 80% NECROTIC. MALIGNANT TUMOR CELLS IN CYTOSPIN PREP.	CLICK TO VIEW
LU5409	Lung Cancer	NSCLC	Non-Small Cell Lung Cancer. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP.	CLICK TO VIEW
LU6266	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU6277	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU6307	Lung Cancer	NSCLC, SCC	squamous cell carcinoma	CLICK TO VIEW
LU6402	Lung Cancer	NSCLC, SCC	Squamous cell Carcinoma - T2a N1 Mx R0	CLICK TO VIEW
LU6403	Lung Cancer	NSCLC, SCC	Non-Small Cell Lung Cancer, SCC	CLICK TO VIEW
LU6404	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma - pT3 pN1 pMx	CLICK TO VIEW
LU6405	Lung Cancer	NSCLC, ADS	Adenosquamous carcinoma Grade 3 - pT2a, N1, Mx	CLICK TO VIEW
LU6406	Lung Cancer	NSCLC, SCC	Poorly differentiated SCC pT1b Nx Mx, V0	CLICK TO VIEW
LU6407	Lung Cancer	NSCLC, SCC	SCC pT2a pN0 pMx complete resection	CLICK TO VIEW
LU6408	Lung Cancer	NSCLC, SCC	SCC of the lung pT3 pN1 pM0, complete resection	CLICK TO VIEW
LU6410	Lung Cancer	NSCLC, ADS	Moderately differentiated adenosquamous carcinoma with clear cell pattern - pT2a, pN0, pMX V0- complete resection	CLICK TO VIEW
LU6411	Lung Cancer	NSCLC, SCC	Moderately differentiated SCC - pT2b, N1, pM0, V0 - complete resection	CLICK TO VIEW
LU6412	Lung Cancer	NSCLC, ADC	Adenocarcinoma of the lung - pT3, pN0, pMX V0- complete resection	CLICK TO VIEW
LU6414	Lung Cancer	NSCLC, ADC	Adenocarcinoma of the lung - pT2a, pN1, pMX V0- complete resection	CLICK TO VIEW
LU6415	Lung Cancer	LCNEC	Large cell neuroendocrine T2a N0 Mx V0	CLICK TO VIEW
LU6416	Lung Cancer	NSCLC, SCC	2 Primaries - larger tumour-SCC T2a, N1, M0, V0. Other tumour- large cell neuroendocrine carcinoma T3.	CLICK TO VIEW
LU6418	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU6419	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma. T2a, N0, M0, R0	CLICK TO VIEW
LU6420	Lung Cancer	NSCLC, SCC	Squamous Cell Carcinoma, T2b, N0, M0, R0	CLICK TO VIEW
LU6421	Lung Cancer	LCNEC	Large Cell Neuroendocrine Carcinoma. T1b, N0, MX, R0	CLICK TO VIEW
LU6422	Lung Cancer	NSCLC, ADC	Adenocarcinoma of the Lung. T2a, N0, M0, R0	CLICK TO VIEW
LU6423	Lung Cancer	NSCLC, SCC	Squamous Cell Carcinoma of the lung. T2a, N0, M0, R0	CLICK TO VIEW
LU6424	Lung Cancer	NSCLC, ADC	NSCLC, ADC	CLICK TO VIEW
LU6425	Lung Cancer	NSCLC, ADC	Adenocarcinoma of the Lung. pT2b, N1, M0, R0.	CLICK TO VIEW
LU6426	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6427	Lung Cancer	NSCLC, ADC	Adenocarcinoma left lung. pT2a, N2, M0, R0	CLICK TO VIEW
LU6428	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6429	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of the Lung. pT3, N0, M0, R0	CLICK TO VIEW
LU6431	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma left lung pT3, pN2 pM0 complete resection - yes	CLICK TO VIEW
LU6432	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6433	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6434	Lung Cancer	NSCLC, SCC	Squamous cell carcinoma of the lung with focal glandular differentiation pT3 N0 M0 V0 R0	CLICK TO VIEW
LU6436	Lung Cancer	NSCLC, SCC	NSCLC, Squamous Cell Carcinoma	CLICK TO VIEW
LU6437	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6438	Lung Cancer	NEC	Poorly differentiated malignant tumour T2a N0 M0 V0 R0. UPDATE- in view of the absence of an alternative primary site we regard this tumour as a poorly differentiated non-small cell carcinoma of the lung.	CLICK TO VIEW
LU6439	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6440	Lung Cancer	NSCLC, SCC	Poorly differentiated SCC. pT2a, pN0, pM0, V0, R0	CLICK TO VIEW
LU6442	Lung Cancer	NSCLC, ADC	NSCLC, ADC	CLICK TO VIEW
LU6471	Lung Cancer	NSCLC, SCC	Moderately differentiated SCC - pT2b, N1, pM0, V0 - complete resection	CLICK TO VIEW
LU6473	Lung Cancer	LCNEC	LCNEC	CLICK TO VIEW
LU6477	Lung Cancer	NSCLC, SCC	NA	CLICK TO VIEW
LU6479	Lung Cancer	NSCLC, SCC	N/A	CLICK TO VIEW
LU6481	Lung Cancer	NSCLC, SCC	N/A	CLICK TO VIEW
LU6483	Lung Cancer	N/A	N/A	CLICK TO VIEW
LU6484	Lung Cancer	NSCLC, SCC	NSCLC, SCC	CLICK TO VIEW
LU6800	Lung Cancer	NSCLC	NA for clinical diagnosis info.	CLICK TO VIEW
LU6802	Lung Cancer	NSCLC	NA for clinical diagnosis info.	CLICK TO VIEW
LU6901	Lung Cancer	NSCLC, SCC	Poorly differentiated squamous cell carcinoma	CLICK TO VIEW
LU6903	Lung Cancer	NSCLC	NA for clinical diagnosis info.	CLICK TO VIEW
LU6904	Lung Cancer	ADC	Lung: poorly differentiated adenocarcinoma	CLICK TO VIEW
LU6905	Lung Cancer	NSCLC	NA for clinical diagnosis info.	CLICK TO VIEW
LU6907	Lung Cancer	NSCLC	Lung, sarcoma	CLICK TO VIEW
LU6908	Lung Cancer	NSCLC	Poorly differentiated squamous cell carcinoma	CLICK TO VIEW
LU6910	Lung Cancer	SCC	Lung: poorly differentiated squamous cell carcinoma	CLICK TO VIEW
LU6911	Lung Cancer	NSCLC	NA for clinical diagnosis info.	CLICK TO VIEW
LU6912	Lung Cancer	NSCLC, ADC	Poorly differentiated adenocarcinoma	CLICK TO VIEW
LU6913	Lung Cancer	NSCLC, SCC	Well differentiated squamous cell carcinoma	CLICK TO VIEW
LU6914	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU6917	Lung Cancer	NSCLC, SCC	Moderately differentiated squamous cell carcinoma	CLICK TO VIEW
LU6918	Lung Cancer	NSCLC, ADC	Poorly differentiated adenocarcinoma	CLICK TO VIEW
LU6919	Lung Cancer	NSCLC, SCC	Well differentiated squamous cell carcinoma	CLICK TO VIEW
LU6920	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU6921	Lung Cancer	SCC	Lung: poorly differentiated squamous cell carcinoma	CLICK TO VIEW
LU6922	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU6923	Lung Cancer	NA	NA for clinical diagnosis info.	CLICK TO VIEW
LU9328	Lung Cancer	NSCLC, ADC	N/A	CLICK TO VIEW
LU9333	Lung Cancer	SCC	NA	CLICK TO VIEW
LU9334	Lung Cancer	SCC	NA	CLICK TO VIEW
LU9335	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU9339	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU9342	Lung Cancer	NSCLC	N/A	CLICK TO VIEW
LU9348	Lung Cancer	NA	NA	CLICK TO VIEW
LU9349	Lung Cancer	NA	NA	CLICK TO VIEW
LU9357	Lung Cancer	SCC	NA	CLICK TO VIEW
LU9358	Lung Cancer	NSCLC, SCC	NA	CLICK TO VIEW
LU9359	Lung Cancer	NSCLC, ADC	NA	CLICK TO VIEW

…

Create Account to View All Model Data

First Name*

Last Name*

Company*

E-mail address*

Job Role

Country/Region*

Create Your Password*

Already Registered? Login

Patient-Derived Xenograft Models of Lung Cancer

Benefits of Crown Bioscience's Lung Cancer PDX Models

Sorry, no posts matched your criteria.

Create Account to View All Model Data

About Us

Our Services

Resources

Platforms

Talk To Us